Thursday, July 11, 2019

GlaxoSmithKline Scores High in Quality

I created a portfolio of the top pharmaceutical companies trading in the US and ran a quality of earnings analysis on them.  With the highest possible score being nine, GSK scored the best with seven.

Here are the results:

Quality of Earnings - Major Pharmaceuticals
Here's the balance of the companies in the portfolio.  We can see that AZN was the worst at two.
Quality of Earnings - Major Pharmaceuticals 2

Just for laughs, lets see how GSK and AZN have performed from a price perspective.

Interestingly, AZN has been outperforming GSK. It'll be interesting to say if this trend will continue or if it will, more correctly I believe, reverse.

No comments:

Post a Comment